Enbridge Inc
ENB
TC Energy Corp
TRP
The Toronto-Dominion Bank
TD
TELUS Corp
T
Emera Inc
EMA
CA Stock MarketDetailed Quotes
TTI Thiogenesis Therapeutics Corp
- 0.590
- 0.0000.00%
15min DelayMarket Closed Jan 6 16:00 ET
27.16MMarket Cap-6.56P/E (TTM)
0.000High0.000Low0Volume0.000Open0.590Pre Close0.00Turnover1.06052wk High0.00%Turnover Ratio46.03MShares0.52052wk Low-0.09EPS TTM20.85MFloat Cap1.060Historical HighLossP/E (Static)35.34MShs Float0.375Historical Low-0.13EPS LYR0.00%Amplitude--Dividend TTM6.56P/B1Lot Size--Div YieldTTM
About Thiogenesis Therapeutics Corp Company
Thiogenesis Therapeutics Corp is a clinical-stage biotech company. The Company is developing thiol-active therapeutic compounds, that are prodrugs, used to treat unmet pediatric medical needs. TTI-0102, the Company’s compound, was developed to address the obstacles facing previous thiol-based drugs, their short half-live, and side effects and it's initial applications are for mitochondrial disease, Rett syndrome, and pediatric NASH.
Company Profile
SymbolTTI
Company NameThiogenesis Therapeutics Corp
Founded2018
MarketTSX
Fiscal Year Ends12-31
Address4 King Street West Suite 401
CityToronto
CountryCAN
Zip CodeM5H 1B6
Phone+1 647 846-7766
Websitehttps://www.thiogenesis.com
Company Executives
- Name
- Position
- Salary
- Dr. Patrice P. Rioux,M.D.,PhD
- Director, Co-President and Chief Executive Officer
- --
- Brook G. Riggins, C.F.A.
- Director and Chief Financial Officer, Secretary
- --
- Dr. Christopher M. Starr,PhD
- Chairman of the Board
- --
- Kim R. Tsuchimoto
- Independent Director
- --
- W Hogan Mullally
- Independent Director
- --
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.